EXPLOIT IMMUNE SIGNATURES FROM IMMUNOTHERAPY RESPONSE IN METASTATIC RENAL CELL CANCER TO IMPROVE QUALITY OF LIFE AND SURVIVAL OF VETERANS

The Medical University Of South Carolina

Investigators